Unrealized gain now stands at $142 million1 TAMPA, Fla., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today released its periodic update. “The last several weeks were extremely strong for Upexi, highlighted by a substantial increase in the price of SOL,” stated Upexi CEO Allan Marshall. “As a result, our Solana treasury now stands at $447 m ...

Robin Energy Ltd. (NASDAQ: RBNE) has completed its initial allocation of $5 million in Bitcoin on September 10, confirming a strategic pivot in treasury management for the international energy transportation company. The firm executed this allocation through Anchorage Digital Bank N.A., following the board’s approval and its August 5 announcement. The move is designed to optimize Robin Energy’s operational efficiency and align its treasury policy with changing market conditions in digital assets. CEO Pet ...

Core Points - Digital Commodities Capital Corp. has successfully closed a Bitcoin purchase under the VanCrypto facility, acquiring a total of 0.317 Bitcoin, increasing its treasury holdings to 10.880 Bitcoin [1][2] - In exchange for the Bitcoin, the company issued 714,285 units at a deemed price of $0.07 per unit, each unit consisting of one common share and one warrant exercisable at $0.10 for two years [2] - The Bitcoin acquired is part of the company's treasury management strategy, viewed as a liquid cash alternative and a hedge against inflation [3] Stock Options - The company granted 4,000,000 stock options to directors, officers, and consultants, exercisable at $0.075 per common share for 24 months from the grant date [4] Company Overview - Digital Commodities focuses on acquiring and utilizing Bitcoin and gold as stores of value, aiming to manage a hard, non-fiat asset base with transparency and discipline [5]

Core Viewpoint - Liminatus Pharma, Inc. is exploring the inclusion of regulated digital asset strategies in its treasury management to enhance capital efficiency while maintaining its focus on developing cancer immunotherapies [1][2][3] Group 1: Company Overview - Liminatus Pharma, Inc. is a preclinical-stage biopharmaceutical company focused on developing targeted cancer immunotherapies [4] - The company is advancing a pipeline of novel therapies that target cancer antigens and tumor-specific immune responses [4] Group 2: Strategic Review - The internal review aims to assess innovative financial instruments, including blockchain-based assets, to enhance treasury efficiency and diversify non-operating capital reserves [2][3] - The review is part of the company's commitment to strong financial stewardship and balance sheet optimization [2] Group 3: Management's Commitment - The CEO of Liminatus emphasizes that the company remains committed to developing life-changing cancer therapies while responsibly managing its treasury [3] - The exploration of digital assets is described as an exploratory process, with no current agreements in place regarding their acquisition or use [3]

Solana DAO Governance Update - Realms v2 is live, marking the next chapter for onchain governance on Solana [1] - Realms v2 is designed for the next wave of DAOs, emphasizing speed and sharpness [1] Key Features of Realms v2 - Realms v2 offers advanced treasury management capabilities [1] - Realms v2 provides transparent voting heat maps [1] - Realms v2 includes mobile support and is fully open source [1]